Showing results (551-560 of 4,380) with videos related to

Sort By:
Pageof 438
IBRO Neuroscience Reports|August 19, 2024
Two hub genes of bipolar disorder, a bioinformatics study based on the GEO databasePing Sun, Shunkang Feng, Hui Yu, et al.
Chemistry, an Asian Journal|June 16, 2024
Fabrication of Porous Adsorbents Templated from Capillary Foam Stabilized with Chlorella for Highly Efficient Removal of Cationic DyesHui Yu, Yongfeng Zhu, Fangzhi Duan, et al.
Molecular Medicine Reports|October 20, 2023
Dracocephalum moldavica L. extract alleviates experimental colitis in rats by modulating gut microbiome and inflammatory pathwaysSuhe Gang, Wenhui Bai, Hui Yu, et al.
Poultry Science|September 20, 2023
Combined 16S and Internal Transcribed Spacer analysis revealed the effect of time on microbial community in animal houseBo Wu, Cheng Lou, Zhuo Chen, et al.
Frontiers in Oncology|May 20, 2026
Correction: Meta-analysis of tuberculosis incidence and risk in cancer patients treated with immune checkpoint inhibitorsHui Ming, Biao Fu, Xiaogang Chen, et al.
Acta Biochimica Et Biophysica Sinica|April 25, 2026
Presenilin 1 is located in the mitochondrial inner inner membrane and regulates mitochondrial cristae junction protein arrangement and cristae formation in HEK293 cellsPan You, Pengjin Zhu, Hui Yu, et al.
Clinical and Translational Science|April 17, 2026
Comparing Whole-Blood and Plasma Tacrolimus Intra-Patient Variability for Predicting Allograft Rejection in Kidney TransplantationZeyu Xia, Hui Yu, Jeong M Park, et al.
Cancer Research|June 23, 2016
Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind LipopolysaccharideWei-Ting Kuo, Tsung-Chun Lee, Linda Chia-Hui Yu
Translational Lung Cancer Research|November 7, 2024
Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysisBaishen Zhang, Jing Chen, Hui Yu, et al.
Therapeutic Advances in Hematology|October 9, 2025
Comparative analysis of once-weekly versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma: a meta-analysisWenhao Yang, Xiangtu Kong, Hui Yu, et al.
Pageof 438